Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.
about
Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort StudyCommunity viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as preventionRates of emergence of HIV drug resistance in resource-limited settings: a systematic review.Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda.Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in CameroonSingle real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina.The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets.First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting.Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C.
P2860
Q28550552-BA6D5B73-DFC2-4645-B27C-4F73282D8A17Q34519553-BED8865D-CE63-4A8B-A10E-38FE4FC9B891Q34969496-20F31B95-BAE8-4479-918B-449476A53CCCQ36419479-12F03561-3597-4834-AB8D-A3713ACC2F35Q36435445-3886E60F-98AB-43E9-8EF3-B283B1D5A32DQ36581795-5DAFE847-48BF-41BE-BBEB-58C3FECEE629Q36667567-621E53DA-F4CD-44A5-A829-03D5F1975822Q37216052-17B17CA0-FC1A-41A3-BAEC-3D1A87E982C0Q37491656-A1995EB8-97F4-4D93-AB77-B55C7AF1B186Q37517997-268E64C1-CEFC-44F4-A4B5-1B3028597358Q37732266-19D3A5F9-97B7-416E-9160-E8765D633D54Q38009758-4DF43889-AF3C-4B8E-9603-317C8C879DBBQ46832256-3FD16151-47F6-46AB-94ED-802281C50D69
P2860
Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@en
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@nl
type
label
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@en
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@nl
prefLabel
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@en
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@nl
P2093
P50
P1476
Resistance to antiretroviral d ...... Democratic Republic of Congo.
@en
P2093
Augustin Okenge
Christelle Butel
Donatien Kayembe Nzongola
Ferdinand Mbayo
François Boillot
Henry Mukumbi
Jean Jacques Muyembe
Jean Lambert Mandjo
Jérémie Muwonga
Marjorie Monleau
P304
P356
10.1097/QAI.0B013E31821F596C
P407
P478
57 Suppl 1
P577
2011-07-01T00:00:00Z